TipRanks
Champions Oncology Inc (DE:2I3)
FRANKFURT:2I3
Germany Market
2I3
Champions Oncology
RESEARCH TOOLSreports

Champions Oncology (2I3) Income Statement

1 Followers

Champions Oncology Income Statement

Last quarter (Q1 2027), Champions Oncology's total revenue was $15.23M, an increase of 8.84% from the same quarter last year. In Q1, Champions Oncology's net income was $-426.00K. See Champions Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Apr 26Apr 25Apr 24Apr 23Apr 22
Total Revenue
$ 59.42M$ 56.94M$ 50.16M$ 53.87M$ 49.11M
Gross Profit
$ 28.52M$ 28.55M$ 20.75M$ 24.34M$ 25.48M
Operating Expenses
$ 29.66M$ 23.71M$ 27.68M$ 28.79M$ 24.87M
Depreciation and Amortization
$ 1.38M$ 1.64M$ 1.87M$ 2.25M$ 1.63M
EBITDA
$ 448.00K$ 6.27M$ -5.44M$ -3.02M$ 2.21M
Operating Income
$ -1.14M$ 4.85M$ -6.92M$ -4.45M$ 607.00K
Other Income/Expenses
$ 211.00K$ -220.00K$ -387.00K$ -818.00K$ -24.00K
Pretax Income
$ -929.00K$ 4.63M$ -7.31M$ -5.27M$ 583.00K
Net Income
$ -1.18M$ 4.70M$ -7.28M$ -5.33M$ 548.00K
Per Share Metrics
Basic EPS
$ -0.08$ 0.34$ -0.54$ -0.39$ 0.04
Diluted EPS
$ -0.08$ 0.33$ -0.54$ -0.39$ 0.04
Weighted Average Shares Outstanding
 13.83M 13.66M 13.55M 13.54M 13.20M
Weighted Average Shares Outstanding (Diluted)
 13.83M 14.27M 13.55M 13.54M 14.16M
Currency in USD

Champions Oncology Earnings and Revenue History